ALEXANDRIA, VA – The National Association of Specialty Pharmacy (NASP) has announced its intent to establish a task force to better educate pharmacists to the management of cannabis therapy. “Medical marijuana has come to the forefront of patient care in many of the diseases that Specialty Pharmacists treat including Multiple Sclerosis, Cancer, HIV and others,” the association stated […]
Read Pharmacy Group Announces Formation Of Medical Marijuana Task Force in its entirety on The Daily Chronic.
Want to stay up to date on marijuana reform & cannabis news worldwide? Visit The Daily Chronic - The Voice of the Reform Generation, the most comprehensive coverage of the cannabis community!
SOURCE: Pharmacy Group Announces Formation Of Medical Marijuana Task Force by NORML
. . . . . READ MOREWASHINGTON, DC – The US Food and Drug Administration has approved two clinical trials to assess the efficacy of cannabidiol (CBD), a nonpsychoactive plant cannabinoid, in the treatment of intractable pediatric epilepsy. The two approved trials will take place at New York Medical School and at the University of California at San Francisco, according to an online report in the […]
Read FDA Approves Clinical Trials Assessing CBD for Pediatric Epilepsy in its entirety on The Daily Chronic.
Want to stay up to date on marijuana reform & cannabis news worldwide? Visit The Daily Chronic - The Voice of the Reform Generation, the most comprehensive coverage of the cannabis community!
SOURCE: FDA Approves Clinical Trials Assessing CBD for Pediatric Epilepsy by NORML
. . . . . READ MORELONDON – Studies have shown that marijuana not only helps fight the symptoms of treating cancer but also the disease itself. THC, or tetrahydrocannabinol, often gets the credit for battling cancer cells, but a new study shows that THC isn’t working alone. The study conducted at St. George’s University of London, led by Dr. Wai Liu, examined six […]
Read More Anti-Cancer Properties of Medical Marijuana Revealed in its entirety on The Daily Chronic.
Want to stay up to date on marijuana reform & cannabis news worldwide? Visit The Daily Chronic - The Voice of the Reform Generation, the most comprehensive coverage of the cannabis community!
SOURCE: More Anti-Cancer Properties of Medical Marijuana Revealed by Marijuana Policy Project
. . . . . READ MORELONDON, UK — The administration of THC, the primary psychoactive component in cannabis, modulates emotional processing in healthy volunteers, according to placebo-controlled crossover trial data published online by the journal European Neuropsychopharmacology. Investigators from the United Kingdom and the Netherlands performed functional magnetic resonance imaging (fMRI) on 11 healthy male subjects. Following the administration of THC or placebo, […]
Read THC Increases Brain Activity in Response to Positive Stimuli in its entirety on The Daily Chronic.
Want to stay up to date on marijuana reform & cannabis news worldwide? Visit The Daily Chronic - The Voice of the Reform Generation, the most comprehensive coverage of the cannabis community!
SOURCE: THC Increases Brain Activity in Response to Positive Stimuli by Paul Armentano
. . . . . READ MOREHAIFA, ISRAEL – The consumption of cannabis is effective in treating symptoms associated with cancer and conventional anti-cancer therapies, such as nausea, weight loss, pain, and fatigue, according to observational study data published in the journal Evidence-Based Complimentary and Alternative Medicine. Israeli investigators surveyed the use of cannabis on various cancer-related symptoms in 131 patients over the course of […]
Read Cannabis Use Associated With ‘Significant Improvement’ In Palliative Oncology Care in its entirety on The Daily Chronic.
Want to stay up to date on marijuana reform & cannabis news worldwide? Visit The Daily Chronic - The Voice of the Reform Generation, the most comprehensive coverage of the cannabis community!
SOURCE: Cannabis Use Associated With ‘Significant Improvement’ In Palliative Oncology Care by Paul Armentano
. . . . . READ MOREThe passage of medical cannabis laws is associated with a reduction in the public’s consumption of alcohol and with fewer incidences of alcohol-related traffic fatalities, according to data published in the Journal of Law and Economics. Investigators at Montana State University, the University of Oregon, and the University of Colorado assessed data regarding both alcohol consumption and traffic […]
Read Study: Passage of Medical Marijuana Laws Associated With Reduced Incidences of Alcohol-Related Traffic Fatalities in its entirety on The Daily Chronic.
Want to stay up to date on marijuana reform & cannabis news worldwide? Visit The Daily Chronic - The Voice of the Reform Generation, the most comprehensive coverage of the cannabis community!
SOURCE: Study: Passage of Medical Marijuana Laws Associated With Reduced Incidences of Alcohol-Related Traffic Fatalities by Paul Armentano
. . . . . READ MOREMarijuana smoking is not associated with the promotion of liver disease in subjects co-infected with both hepatitis C and the human immunodeficiency virus (HIV), according to data published online in the journal Clinical Infectious Diseases.
Investigators at McGill University in Montreal and the University of Toronto assessed the impact of marijuana smoking on liver disease progression longitudinally in a cohort of nearly 700 subjects with HIV and the hepatitis C virus (HCV). Study participants at baseline reported having previously used cannabis, on average, some seven times per week, with 40 percent of subjects acknowledging having consumed cannabis daily.
Participants were monitored over a median period of 32 months.
Investigators reported, “In this prospective analysis we found no evidence for an association between marijuana smoking and significant liver fibrosis progression in HIV/HCV coinfection.”
Authors speculated that previously reported positive associations between cannabis smoking and liver disease progression were likely the result of “reverse causation due to self-medication.”
Researchers concluded:
[I]n this first prospective evaluation of liver disease progression among HIV-HCV infected persons, we could not demonstrate any important effect of marijuana on liver dis. . . . . READ MORE
PHILADELPHIA, PA — Cannabis consumption is associated with mitigated symptoms of opiate withdrawal in subjects undergoing methadone maintenance treatment, according to the findings of a new study published online in The American Journal on Addictions.
Investigators at the Farber Institute for Neurosciences at Thomas Jefferson University in Philadelphia assessed the use of cannabis in 91 opiate-dependent subjects undergoing methadone maintenance treatment. Researchers found that subjects seeking methadone treatment who acknowledged a history of cannabis use reported “significantly less daily expenditure on acquisition of opiates.”
Authors additionally reported that subjects’ use of cannabis during treatment was associated with less severe symptoms of withdrawal on the clinical opiate withdrawal scale (COWS), an index designed to serve as an objective measure of opiate withdrawal. “[I]ncreased cannabis use was found to be associated with lower severity of [opiate] withdrawal in a subset of the sample with available chart data,” authors wrote. “These results suggested a potential role for cannabis in the reduction of withdrawal severity during methadone induction.”
They concluded, “The present findings may point to novel interventions to be employed during treatment for opiate dependence that specifically target cannabinoid–opioid system interactions.”
A 200. . . . . READ MORE
Pulmonary complications associated with the regular smoking of cannabis are “relatively small” and far lower than those associated with tobacco smoking, according to a recent review published in the June edition of the scientific journal Annals of the American Thoracic Society.
The paper – authored by Donald P. Tashkin, MD, emeritus professor of medicine and medical director of the Pulmonary Function Laboratory at the David Geffen School of Medicine at University of California, Los Angeles – is “the most comprehensive and authoritative review of the subject ever published,” according to an accompanying commentary. Donald Tashkin conducted US-government sponsored studies of marijuana and lung function for over 30 years.
His review finds that although smoking cannabis may be associated with symptoms of chronic bronchitis, studies do not substantiate claims that it is positively associated with the development of lung cancer, chronic obstructive pulmonary disease (COPD), emphysema, or bullous lung disease.
“[H]abitual use of marijuana alone does not appear to lead to significant abnormalities in lung function,” Tashkin writes. “[F]indings from a limited number of well-designed epidemiological studies do not suggest an increased risk of either lung or upper airway cancer from light or moderate use. … Overall. . . . . READ MORE